Clodronate liposomes
Based on 9 publication(s) in Google Scholar
Clodronate liposomes, a mixture of Clodronate encapsulated by phospholipids, is a macrophage scavenger. Clodronate liposomes is engulfed by macrophages in the body. Under the action of lysosomal phosphatases in macrophages, Clodronate dissolved in liposomes will be gradually released and accumulated in cells. When a certain concentration is reached, macrophages will be irreversibly damaged and apoptosis will be induced.
For research use only. We do not sell to patients.
-
Storage:
Store at 4°C, do not freeze
Publications Citing Use of MedChemExpress (MCE) Clodronate liposomes
More- Cancer Commun (Lond). 2025 Oct 13. [Abstract]
- Cancer Res. 2026 Mar 5. [Abstract]
- Cancer Res. 2025 Nov 6. [Abstract]
- J Control Release. 2025 Oct 28:114367. [Abstract]
- Gut Microbes. 2026 Dec 31;18(1):2635820. [Abstract]
- Phytomedicine. 2025 Oct:146:157117. [Abstract]
- Cell Mol Gastroenterol Hepatol. 2026 Mar 2:101765. [Abstract]
- Cell Oncol (Dordr). 2026 Mar 23;49(2):61. [Abstract]
- FASEB J. 2025 Aug 15;39(15):e70923. [Abstract]
-
IF
-
In Vivo Efficacy Study
-
Histological Imaging/Staining
Biological Activity
Clearing red pulp area of spleen and Kupffer macrophages:
Single dose: 200 μL/mouse (intravenous or intraperitoneal injection).
Long-term administration: The first dose is 150 μL/mouse, and then 100 μL/mouse every three days.
Depletion of alveolar macrophages
The best effect was obtained by intravenous injection (150-200 μL) combined with tracheal or intranasal administration (50 μL).
Depletion of brain microglia
Intraventricular cerebrospinal fluid injection, mice (10 μL), rats (50 μL).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Liquid
-
Color Milky white to off-white
-
SMILES
[Clodronate liposomes]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at 4°C, do not freeze
Publications (9)
-
Journal Impact Factor
-
Most Recent
-
Cancer Commun (Lond)
CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer. [Abstract]2025 Oct 13. PMID: 41084191 -
Cancer Res
Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity. [Abstract]2026 Mar 5. PMID: 41784618 -
Cancer Res
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Co-evolution in Pancreatic Cancer. [Abstract]2025 Nov 6. PMID: 41196022 -
J Control Release
Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment. [Abstract]2025 Oct 28:114367. PMID: 41167336 -
Gut Microbes
Simulated microgravity induces cerebral dysfunction by disturbing protective microbiota-metabolite-microglia signaling across the gut‒brain ax is. [Abstract]2026 Dec 31;18(1):2635820. PMID: 41729099 -
Phytomedicine
Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer. [Abstract]2025 Oct:146:157117. PMID: 40812220 -
Cell Mol Gastroenterol Hepatol
Ubiquitin-Conjugating Enzyme E2O Primes Hepatocytes to Restore Immune Tolerance in Autoimmune Hepatitis via Inhibiting Y-Box Binding Protein 1/Interleukin-6 Axis. [Abstract]2026 Mar 2:101765. PMID: 41780884 -
Cell Oncol (Dordr)
Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer. [Abstract]2026 Mar 23;49(2):61. PMID: 41870812
Clodronate liposomes purchased from MedChemExpress. Usage Cited in: Cell Oncol (Dordr). 2026 Mar 23;49(2):61. [Abstract]
Verification of macrophage deletion by Clodronate liposomes. Clodronate liposomes (40 mg/kg; i.p.) were administered twice weekly for two weeks before tumor inoculation and then weekly for four additional weeks. IF analysis of F4/80+ macrophages in the following groups: PBS-liposomes, ADM, Clodronateliposome, or ADM + Clodronate-liposome. Scale bar, 50 μm.
-
FASEB J
M2c Macrophages Mediate YAP1 to Promote Vascularized Bone Regeneration in Distraction Osteogenesis. [Abstract]2025 Aug 15;39(15):e70923. PMID: 40788163
Clodronate liposomes purchased from MedChemExpress. Usage Cited in: FASEB J. 2025 Aug 15;39(15):e70923. [Abstract]
Representative micro‐CT images showing new bone formation in each group. Both the YAP1 inhibitor group and the Clodronate liposomes group exhibited impaired bone regeneration compared to the Ctrl group.
Clodronate liposomes purchased from MedChemExpress. Usage Cited in: FASEB J. 2025 Aug 15;39(15):e70923. [Abstract]
H&E staining and Masson's trichrome staining showed dense lamellar bone formation in the Ctrl group, while the YAP1 inhibitor and Clodronate liposomes groups exhibited sparse trabeculae, fibrous tissue infiltration, or immature callus.
Purity & Documentation
-
Data Sheet (268 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)